-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Protagonist Therapeutics, Raises Price Target to $160

Benzinga·10/21/2026 15:07:17
Listen to the news
TD Cowen analyst Tara Bancroft maintains Protagonist Therapeutics (NASDAQ:PTGX) with a Buy and raises the price target from $155 to $160.